Patent · US Active

Small molecule inhibitors of BCL6

US8338464B2 · kind B2 · utility

27Cited by
1References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 29, 2007
Grant dateDec 25, 2012
Priority date—
Expiry dateAug 7, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are methods of inhibiting BCL6 repression in a mammalian cell. Also provided are methods of treating cancer in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.